Sputum exosomes: promising biomarkers for idiopathic pulmonary fibrosis

被引:94
|
作者
Njock, Makon-Sebastien [1 ]
Guiot, Julien [2 ,3 ]
Henket, Monique A. [2 ,3 ]
Nivelles, Olivier [1 ]
Thiry, Marc [4 ]
Dequiedt, Franck [5 ]
Corhay, Jean-Louis [2 ,3 ]
Louis, Renaud E. [2 ,3 ]
Struman, Ingrid [1 ]
机构
[1] Univ Liege, Lab Mol Angiogenesis, GIGA R, Liege, Belgium
[2] CHU Liege, Pneumol Dept, Liege, Belgium
[3] Univ Liege, Lab Pneumol, GIGA I3, Liege, Belgium
[4] Univ Liege, Lab Biol Cellulaire & Tissulaire, GIGA R, Liege, Belgium
[5] Univ Liege, Lab Signalisat & Interact Prot, GIGA R, Liege, Belgium
关键词
idiopathic pulmonary fibrosis; interstitial fibrosis;
D O I
10.1136/thoraxjnl-2018-211897
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrosing interstitial lung disease of unknown aetiology which leads rapidly to death. As diagnosis of IPF is complex, we aimed to characterise microRNA (miRNA) content of exosomes from sputum of patients with IPF. Using miRNA quantitative PCR array, we found a substantial dysregulation of sputum exosomal miRNA levels between patients with IPF and healthy subjects and identified a unique signature of three miRNAs. Interestingly, we found a negative correlation between miR-142-3p and diffusing capacity of the lungs for carbon monoxide/alveolar volume. This is the first characterisation of miRNA content of sputum-derived exosomes in IPF that identified promising biomarkers for diagnosis and disease severity.
引用
收藏
页码:309 / 312
页数:4
相关论文
共 50 条
  • [1] Sputum Exosomal microRNAs as Promising Biomarkers for Idiopathic Pulmonary Fibrosis
    Guiot, J.
    Njock, M.
    Henket, M.
    Nivelles, O.
    Thiry, M.
    Dequiedt, F.
    Corhay, J.
    Louis, R.
    Struman, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [2] The levels of trace elements in sputum as biomarkers for idiopathic pulmonary fibrosis
    Forte, Giovanni
    Bocca, Beatrice
    Pisano, Andrea
    Collu, Claudia
    Farace, Cristiano
    Sabalic, Angela
    Senofonte, Marta
    Fois, Alessandro Giuseppe
    Mazzarello, Vittorio Lorenzo
    Pirina, Pietro
    Madeddu, Roberto
    CHEMOSPHERE, 2021, 271
  • [3] Sputum eosinophilia in idiopathic pulmonary fibrosis
    S. S. Birring
    D. Parker
    S. McKenna
    B. Hargadon
    C. E. Brightling
    I. D. Pavord
    P. Bradding
    Inflammation Research, 2005, 54 : 51 - 56
  • [4] Sputum eosinophilia in idiopathic pulmonary fibrosis
    Birring, SS
    Parker, D
    McKenna, S
    Hargadon, B
    Brightling, CE
    Pavord, ID
    Bradding, P
    INFLAMMATION RESEARCH, 2005, 54 (02) : 51 - 56
  • [5] Biomarkers in idiopathic pulmonary fibrosis
    Drakopanagiotakis, F.
    Wujak, Lukasz
    Wygrecka, Malgorzata
    Markart, P.
    MATRIX BIOLOGY, 2018, 68-69 : 404 - 421
  • [6] Biomarkers in idiopathic pulmonary fibrosis
    Zhang, Yingze
    Kaminski, Naftali
    CURRENT OPINION IN PULMONARY MEDICINE, 2012, 18 (05) : 441 - 446
  • [7] Pathophysiological involvement of exosomes in idiopathic pulmonary fibrosis
    Stoeberl, Anna S.
    Krieger, Sigurd
    Kain, Renate
    Geleff, Silvana
    WIENER KLINISCHE WOCHENSCHRIFT, 2019, 131 (19-20) : 529 - 529
  • [8] Molecular biomarkers in idiopathic pulmonary fibrosis
    Ley, Brett
    Brown, Kevin K.
    Collard, Harold R.
    AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2014, 307 (09) : L681 - L691
  • [9] Blood Biomarkers in Idiopathic Pulmonary Fibrosis
    Julien Guiot
    Catherine Moermans
    Monique Henket
    Jean-Louis Corhay
    Renaud Louis
    Lung, 2017, 195 : 273 - 280
  • [10] Serum biomarkers in idiopathic pulmonary fibrosis
    van den Blink, Bernt
    Wijsenbeek, Marlies S.
    Hoogsteden, Henk C.
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 2010, 23 (06) : 515 - 520